投稿咨詢
Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas.
ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes.
ARS coverage includes:
-ROS/RNS as messengers
-Gaseous signal transducers
-Hypoxia and tissue oxygenation
-microRNA
-Prokaryotic systems
-Lessons from plant biology
《Antioxidants & Redox Signaling》是一本由MARY ANN LIEBERT, INC出版商出版的專業生物期刊，該刊創刊于1999年，刊期Semimonthly，該刊已被國際權威數據庫SCIE、SCI收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：生物學 2區，小類學科：生化與分子生物學 2區；內分泌學與代謝 2區；在JCR（Journal Citation Reports）分區等級為Q1。該刊發文范圍涵蓋生化與分子生物學等領域，旨在及時、準確、全面地報道國內外生化與分子生物學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為7.468，平均審稿速度一般,3-6周。
| 大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
| 生物學 | 2區 | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 ENDOCRINOLOGY & METABOLISM 內分泌學與代謝 | 2區 2區 | 否 | 否 |
| JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
| Q1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | Q1 | 7.468 |
| ENDOCRINOLOGY & METABOLISM | Q1 |
| 影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
| 7.468 | 162 | 9.40% | 90.76% | 未開放 | 一般,3-6周 |
課題、SCI/EI/SSCI怎么寫？